Zheng Yanlei, Hu Ronghua, Zhang Li, Li Shi
Department of Intensive Care Medicine, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, Hubei, China. Corresponding author: Li Shi, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1299-1303. doi: 10.3760/cma.j.cn121430-20200724-00541.
To follow up the cured and discharged patients with coronavirus disease 2019 (COVID-19) from Wuhan Mobile Cabin Hospital and investigate their epidemiological and clinical characteristics as well as 2019 novel coronavirus (2019-nCoV) nucleic acid test results, so as to provide evidence for epidemic prevention and control.
The clinical data including epidemiology, clinical symptoms, laboratory and imaging data of 117 patients diagnosed with COVID-19 who were admitted to Wuhan Hongshan Mobile Cabin Hospital from February 6 to March 10, 2020 were collected by telephone follow-up and analyzed, so as to provide evidence for the prevention and treatment of COVID-19.
Among the 117 COVID-19 patients who met the discharge criteria, there were 49 males and 68 females with an average age of (49.00±11.88) years old, and the average length of hospital stay was (17±6) days. Among them, 91 patients had no obvious symptoms after discharge, and the proportion of asymptomatic patients was 77.78%. A small number of patients had clinical symptoms such as chest distress, palpation and asthma, etc. after discharge. After discharge, 7 patients had chest distress symptom, 5 cases had sore throat and palpitate symptom, 4 patients still had cough, asthma and chest pain existed in 3 cases for each, and headache, diarrhea, difficulty in breathing existed in 1 case for each. The 2019-nCoV nucleic acid results of 7 discharged patients were positive, with a re-positive rate of about 5.98%. The nucleic acid positive result occurred after 10-19 days in meeting the discharge standard. Most of the patients did not receive chest CT scan after discharge, but 24 cases of the patients received chest CT scan during follow-up showed normal manifestations, and the lesions of 6 patients were all almost absorbed or normal.
Some patients with COVID-19 in Wuhan Mobile Cabin Hospital who were re-positive with 2019-nCoV nucleic acid after discharge did not cause further transmission. Moreover, the patients with re-positive nucleic acid results were not significantly correlated with their length of hospital stay and the presence of clinical symptoms after discharge as well as CT findings. It is recommended to detect feces or other specimens in discharged patients, and to strengthen the regular monitoring and follow-up of discharged patients.
对武汉方舱医院治愈出院的新型冠状病毒肺炎(COVID-19)患者进行随访,调查其流行病学及临床特征以及新型冠状病毒(2019-nCoV)核酸检测结果,为疫情防控提供依据。
通过电话随访收集2020年2月6日至3月10日收治于武汉洪山方舱医院的117例确诊为COVID-19患者的流行病学、临床症状、实验室及影像学资料等临床数据并进行分析,为COVID-19的防治提供依据。
117例符合出院标准的COVID-19患者中,男性49例,女性68例,平均年龄(49.00±11.88)岁,平均住院天数(17±6)天。其中91例患者出院后无明显症状,无症状患者比例为77.78%。少数患者出院后有胸闷、心悸、气喘等临床症状。出院后有7例患者有胸闷症状,5例有咽痛、心悸症状,4例仍有咳嗽,3例各有气喘、胸痛,各有1例有头痛、腹泻、呼吸困难。7例出院患者的2019-nCoV核酸结果为阳性,复阳率约为5.98%。核酸阳性结果出现在达到出院标准后10-19天。多数患者出院后未行胸部CT检查,但24例患者随访期间行胸部CT检查显示表现正常,6例患者病变均基本吸收或正常。
武汉方舱医院部分COVID-19患者出院后2019-nCoV核酸复阳未造成进一步传播。且核酸复阳结果与患者住院天数、出院后临床症状及CT表现无明显相关性。建议对出院患者检测粪便等标本,并加强对出院患者的定期监测和随访。